STOCK Hmox1tm1.2Gkl/Flmg
Status | Available to order |
EMMA ID | EM:08992 |
International strain name | STOCK Hmox1tm1.2Gkl/Flmg |
Alternative name | B6.129-Hmox1 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Hmox1tm1.2Gkl, |
Gene/Transgene symbol | Hmox1 |
Information from provider
Provider | George Kollias |
Provider affiliation | BSRC Al. Fleming |
Genetic information | Germ line, cre mediated recombination was used to remove exon 3 through 4. The absence of protein expression was confirmed by Western blot analysis on thioglycollate-stimulated peritoneal macrophage. |
Phenotypic information | Homozygous:Partial embryonic lethality is displayed. Mice appear to be anemic and develop a progressive chronic inflammatory disease characterized by enlarged spleens and hepatic inflammatory lesions. They die within 6 months because of presumed multi-organ failure.Heterozygous:No overt pathology. Mice exhibit fertility problems. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
Animals used for archiving | heterozygous C57BL/6, wild-type C57BL/6 |
Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Heme oxygenase-1 deficiency / Orphanet_562509
MGI phenotypes (allele matching)
Literature references
- Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production.;Tzima Sotiria, Victoratos Panayiotis, Kranidioti Ksanthi, Alexiou Maria, Kollias George, ;2009;The Journal of experimental medicine;206;1167-79; 19398754
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).